We analyzed SRPK1 expression in tissues obtained from 65 NSCLC patients with EGFR mutations and classified the staining scores into two groups according to the optimal cut-off value from ROC curve analysis. This evidence concerns the gene SRPK1 and non-small cell lung carcinoma.